Until now, however, doctors have limited the test's use to confirmation of heart failure, a progressive illness in which the heart can no longer efficiently pump blood to other organs and muscles.
The researchers found that in the placebo group, the risk of heart disease was almost double among the men with short telomeres compared with counterparts with long telomeres.
The risk of a complication, especially heart failure, increased as the NT-proBNP level rose.
A certain gene variant predisposes women to heart disease, a new US study has found, offering clues to the origins of heart attacks and strokes.
